Showing 1 - 6 of 6
DOI: 10.2165/0019053-200826100-00009
Persistent link: https://www.econbiz.de/10004997788
While the EuroQOL instrument (EQ-5D) is being considered and used in clinical trials in the United States and Canada, and in large international multicentre studies, population weights for the instrument have never been established in North America. The primary purpose of this investigation was...
Persistent link: https://www.econbiz.de/10005404803
With the advent of highly active antiretroviral therapy (HAART), HIV-infected patients are living longer and are concerned not only with a treatment's ability to extend their life but also with the quality of the life they are able to lead. Regulatory authorities are also paying closer attention...
Persistent link: https://www.econbiz.de/10005590447
Uncertainty in the decision-making process for reimbursement of health technologies could be reduced if additional information were available. Although methods to evaluate the monetary value of the uncertainty have been previously described, an economic evaluation of alternative methods to...
Persistent link: https://www.econbiz.de/10005590472
While health care quality has been improving on average in OECD members countries, patient safety remains a central priority for policy makers and health care leaders. A growing research body has found that PSC is associated with numerous positive outcomes, including improved health outcomes,...
Persistent link: https://www.econbiz.de/10012227468
The OECD has been leading the work on international comparisons of patient-reported experience measures (PREMs) across its member states for over a decade. This paper synthesises national developments in relation to measuring and monitoring PREMs between 2006 and 2016 across countries...
Persistent link: https://www.econbiz.de/10011822307